ECOG Randomized Phase III Trial Comparing Two Different Rituximab Dosing Regimens for Patients with Low Tumor Burden Indolent Non-Hodgkin's Lymphoma Adult CIRB - Late Phase Emphasis Closed to Accrual. Pts Still Rcving Intervention Available to Open